Erratum to “Anti-Inflammatory Effect of 3-Bromo-4,5-Dihydroxybenzaldehyde, a Component of Polysiphonia morrowii, In Vivo and In Vitro” [Toxicol. Res. 33 (2017) 325–332]
Toxicological Research 2018;34:83−83
Published online January 15, 2018;
© 2018 Korean Society of Toxicology.

Na-Jin Kang1, Sang-Chul Han1, Hyun-Jae Kang1, Geum Ko1, Weon-Jong Yoon2, Hee-Kyoung Kang1, and Eun-Sook Yoo1

1Department of Medicine, School of Medicine, Jeju National University, Jeju, Korea, 2Jeju Biodiversity Research Institute (JBRI), Jeju Technopark (JTP), Jeju, Korea
Eun-Sook Yoo, Department of Medicine, School of Medicine, Jeju National University, Jeju 63243, Korea, E-mail:
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

On page 327 and 328, the authors found labeling errors in Fig. 2B and Fig. 3B. Fig. 2B is originally result for “IgE levels” but was erroneously expressed as “ear thickness”. Therefore author wanted to change from Fig. 2B ear thickness results to IgE levels and from Fig. 3B to corrected “ear thickness” results.

3-Bromo-4,5-dihydroxybenzaldehyde suppresses the expression of serum IgE.

3-Bromo-4,5-dihydroxybenzaldehyde suppresses experimental atopic dermatitis.


This Article